By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

DND Technologies, Inc. (DNDT)

OTC Currency in USD
$0.06
$0.00
0.00%
Last Update: 11 Sept 2025, 00:00
$193.62K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.04 - $0.20
52 Week Range

DNDT Stock Price Chart

Explore DND Technologies, Inc. interactive price chart. Choose custom timeframes to analyze DNDT price movements and trends.

DNDT Company Profile

Discover essential business fundamentals and corporate details for DND Technologies, Inc. (DNDT) to support your stock research and investment decisions.

Sector

Consumer Defensive

Industry

Beverages - Non-Alcoholic

IPO Date

16 Jan 2013

Employees

Website

CEO

David Hong

Description

DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.

DNDT Financial Timeline

Browse a chronological timeline of DND Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

DNDT Stock Performance

Access detailed DNDT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run